Effects of the opioid antagonist naloxone on release of luteinizing hormone in mares during the anovulatory season.

The research paper discusses an investigation into the role of endogenous opioids in regulating annual changes in the reproductive activity of mares during anovulatory seasons. The study involved the use of the opioid antagonist naloxone and measuring its effects on the concentration of luteinizing hormone (LH) in mares’ plasma.

Research Methodology

• The research employed the use of naloxone, an opioid antagonist, to study its impact on LH concentrations in the mares during their anovulatory season.
• The dosage for naloxone was set at 0.5 mg/kg, administered intravenously.
• Measurement of the immunoreactive and bioactive LH in the plasma was done for comparative analysis
• The research further utilized an in vitro bioassay to measure the increase in LH concentrations.

Findings of the Research

• Naloxone caused a substantial increase in both immunoreactive and bioactive LH concentration in plasma.
• The extent of increase in LH concentrations measured with the in vitro bioassay was more pronounced compared to the increase in LH secretion determined by radioimmunoassay.
• Even in the absence of ovulation in mares, highly bioactive LH is present in the anterior pituitary and can be released by naloxone.
• The release of LH in response to naloxone did not depend on the ovarian follicular activity degree.

Conclusions Drawn from the Study

• A continuous opioid inhibition of LH release exists in mares during at least part of the anovulatory season.
• Endogenous opioids appear to be involved in the regulation of seasonal reproductive activity in horses.
• Unlike during the breeding season, opioids that regulate LH release are activated regardless of the luteal progesterone presence.

The study concludes by suggesting the role of endogenous opioids in regulating the reproductive cycle in mares, specifically in relation to the effect of naloxone on the release of LH. This research provides insight into the potential for medical interventions to manage ovarian activities during the anovulatory seasons in mares, opening up pathways for further studies.